GPR68 expression is significantly elevated in the inflamed mucosa of patients with IBD, particularly in those with Crohn’s disease and ulcerative colitis, where its expression levels correlate positively with disease severity (de Vallière et al., 2022). Here, GPR68 is linked to inflammatory bowel disease.